瑞思迈公司在2024财年第一季度释放了喜人的业绩,推动股价在10月25日盘中大涨8.85%。财报数据显示,上一季度,该公司实现调整后每股收益2.2美元,超过分析师预期。总收入同比增长11%至12.2亿美元,也高于市场预期。
公司表示,业绩增长主要得益于其用于治疗睡眠呼吸暂停的设备和相关面罩产品组合需求强劲。作为该领域的领导者,瑞思迈在核心业务领域展现出了巨大的市场潜力,这令投资者看好其长期前景。分析师预计,即便未来市场环境变化,瑞思迈明年在无创睡眠呼吸暂停治疗领域的产品销量也将保持旺盛。
受超预期业绩和光明长期前景的提振,市场最新预期瑞思迈2025财年每股收益将达到9.25美元,营收将达到50.85亿美元。分析师也上调了对该股的目标价,中位数为262.39美元,较此前上涨近5%,进一步反映出市场对瑞思迈未来发展的乐观预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.